Report cover image

North America Pharma 4.0 Market Size, Share & Trends Analysis Report By Type (Software and Services), By Application, By End Use, By Technology (AI & ML, Big Data Analytics, IoT, Blockchain Technology, and Other Technology), By Country and Growth Forecast

Publisher Knowledge Based Value (KBV) Research
Published Sep 13, 2024
Length 132 Pages
SKU # KBV19169941

Description

North America Pharma 4.0 Market Size, Share & Trends Analysis Report By Type (Software and Services), By Application, By End Use, By Technology (AI & ML, Big Data Analytics, IoT, Blockchain Technology, and Other Technology), By Country and Growth Forecast, 2024 - 2031


The North America Pharma 4.0 Market would witness market growth of 18.0% CAGR during the forecast period (2024-2031).

The US market dominated the North America Pharma 4.0 Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $10,599.3 million by 2031. The Canada market is experiencing a CAGR of 20.5% during (2024 - 2031). Additionally, The Mexico market would exhibit a CAGR of 19.5% during (2024 - 2031).

The core idea of this 4.0 is to create a smart, flexible, and agile production environment where real-time data is continuously gathered and analyzed across every stage of the pharmaceutical lifecycle—from research and drug discovery to production, quality control, and distribution. This enables pharmaceutical companies to make better decisions, optimize production processes, and reduce human error, ultimately leading to faster drug development, higher product quality, and improved regulatory compliance.

This 4.0 is timely, given the rising demand for faster drug development, personalized medicine, and more efficient production processes. Traditional pharmaceutical manufacturing methods, which often involve manual processes and significant human intervention, are no longer sufficient to meet the complex challenges of modern healthcare.

The demand for this 4.0 technologies is rapidly increasing across North America, driven by the region's advanced pharmaceutical industry and growing focus on digital transformation. Governments and pharmaceutical companies are embracing Industry 4.0 technologies such as AI, IoT, and big data to enhance manufacturing, drug discovery, and patient care. The increasing demand for this 4.0 is fueled significantly by strong government initiatives to modernize the pharmaceutical industry in the United States. Thus, the overall landscape in North America reflects a growing commitment to leveraging Pharma 4.0 to improve operational efficiency and patient outcomes.

Based on Type, the market is segmented into Software and Services. Based on Application, the market is segmented into Drug Discovery & Development, Manufacturing, Supply Chain Management, and Other Application. Based on End Use, the market is segmented into Pharma & Biotech companies, CRO & CDMO, and Healthcare Providers. Based on Technology, the market is segmented into AI & ML, Big Data Analytics, IoT, Blockchain Technology, and Other Technology. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

List of Key Companies Profiled
  • Amazon Web Services, Inc.
  • SAP SE
  • Oracle Corporation
  • Microsoft Corporation
  • IBM Corporation
  • GE HealthCare Technologies, Inc.
  • Siemens Healthineers AG (Siemens AG)
  • Cisco Systems, Inc.
  • Dassault Systemes SE
  • UnitedHealth Group, Inc. (Optum, Inc.)
North America Pharma 4.0 Market Report Segmentation

By Type
  • Software
  • Services
By Application
  • Drug Discovery & Development
  • Manufacturing
  • Supply Chain Management
  • Other Application
By End Use
  • Pharma & Biotech companies
  • CRO & CDMO
  • Healthcare Providers
By Technology
  • AI & ML
  • Big Data Analytics
  • IoT
  • Blockchain Technology
  • Other Technology
By Country
  • US
  • Canada
  • Mexico
  • Rest of North America

Table of Contents

132 Pages
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Pharma 4.0 Market, by Type
1.4.2 North America Pharma 4.0 Market, by Application
1.4.3 North America Pharma 4.0 Market, by End Use
1.4.4 North America Pharma 4.0 Market, by Technology
1.4.5 North America Pharma 4.0 Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
Chapter 4. Competition Analysis - Global
4.1 KBV Cardinal Matrix
4.2 Recent Industry Wide Strategic Developments
4.2.1 Partnerships, Collaborations and Agreements
4.2.2 Product Launches and Product Expansions
4.2.3 Acquisition and Mergers
4.3 Market Share Analysis, 2023
4.4 Top Winning Strategies
4.4.1 Key Leading Strategies: Percentage Distribution (2020-2024)
4.4.2 Key Strategic Move: (Partnerships, Collaborations & Agreements: 2023, May – 2024, Sep) Leading Players
4.5 Porter Five Forces Analysis
Chapter 5. North America Pharma 4.0 Market by Type
5.1 North America Software Market by Region
5.2 North America Services Market by Region
Chapter 6. North America Pharma 4.0 Market by Application
6.1 North America Drug Discovery & Development Market by Country
6.2 North America Manufacturing Market by Country
6.3 North America Supply Chain Management Market by Country
6.4 North America Other Application Market by Country
Chapter 7. North America Pharma 4.0 Market by End Use
7.1 North America Pharma & Biotech companies Market by Country
7.2 North America CRO & CDMO Market by Country
7.3 North America Healthcare Providers Market by Country
Chapter 8. North America Pharma 4.0 Market by Technology
8.1 North America AI & ML Market by Country
8.2 North America Big Data Analytics Market by Country
8.3 North America IoT Market by Country
8.4 North America Blockchain Technology Market by Country
8.5 North America Other Technology Market by Country
Chapter 9. North America Pharma 4.0 Market by Country
9.1 US Pharma 4.0 Market
9.1.1 US Pharma 4.0 Market by Type
9.1.2 US Pharma 4.0 Market by Application
9.1.3 US Pharma 4.0 Market by End Use
9.1.4 US Pharma 4.0 Market by Technology
9.2 Canada Pharma 4.0 Market
9.2.1 Canada Pharma 4.0 Market by Type
9.2.2 Canada Pharma 4.0 Market by Application
9.2.3 Canada Pharma 4.0 Market by End Use
9.2.4 Canada Pharma 4.0 Market by Technology
9.3 Mexico Pharma 4.0 Market
9.3.1 Mexico Pharma 4.0 Market by Type
9.3.2 Mexico Pharma 4.0 Market by Application
9.3.3 Mexico Pharma 4.0 Market by End Use
9.3.4 Mexico Pharma 4.0 Market by Technology
9.4 Rest of North America Pharma 4.0 Market
9.4.1 Rest of North America Pharma 4.0 Market by Type
9.4.2 Rest of North America Pharma 4.0 Market by Application
9.4.3 Rest of North America Pharma 4.0 Market by End Use
9.4.4 Rest of North America Pharma 4.0 Market by Technology
Chapter 10. Company Profiles
10.1 Amazon Web Services, Inc. (Amazon.com, Inc.)
10.1.1 Company Overview
10.1.2 Financial Analysis
10.1.3 Segmental Analysis
10.1.4 Recent strategies and developments:
10.1.4.1 Partnerships, Collaborations, and Agreements:
10.1.5 SWOT Analysis
10.2 Oracle Corporation
10.2.1 Company Overview
10.2.2 Financial Analysis
10.2.3 Segmental and Regional Analysis
10.2.4 Research & Development Expense
10.2.5 Recent strategies and developments:
10.2.5.1 Partnerships, Collaborations, and Agreements:
10.2.5.2 Acquisition and Mergers:
10.2.6 SWOT Analysis
10.3 Microsoft Corporation
10.3.1 Company Overview
10.3.2 Financial Analysis
10.3.3 Segmental and Regional Analysis
10.3.4 Research & Development Expenses
10.3.5 Recent strategies and developments:
10.3.5.1 Product Launches and Product Expansions:
10.3.6 SWOT Analysis
10.4 IBM Corporation
10.4.1 Company Overview
10.4.2 Financial Analysis
10.4.3 Regional & Segmental Analysis
10.4.4 Research & Development Expenses
10.4.5 Recent strategies and developments:
10.4.5.1 Partnerships, Collaborations, and Agreements:
10.4.5.2 Acquisition and Mergers:
10.4.6 SWOT Analysis
10.5 SAP SE
10.5.1 Company Overview
10.5.2 Financial Analysis
10.5.3 Regional Analysis
10.5.4 Research & Development Expense
10.5.5 Recent strategies and developments:
10.5.5.1 Partnerships, Collaborations, and Agreements:
10.5.5.2 Acquisition and Mergers:
10.5.6 SWOT Analysis
10.6 GE HealthCare Technologies, Inc.
10.6.1 Company Overview
10.6.2 Financial Analysis
10.6.3 Segmental and Regional Analysis
10.6.4 Research & Development Expenses
10.6.5 Recent strategies and developments:
10.6.5.1 Product Launches and Product Expansions:
10.6.6 SWOT Analysis
10.7 Siemens Healthineers AG (Siemens AG)
10.7.1 Company Overview
10.7.2 Financial Analysis
10.7.3 Segmental and Regional Analysis
10.7.4 Research & Development Expense
10.7.5 Recent strategies and developments:
10.7.5.1 Partnerships, Collaborations, and Agreements:
10.7.6 SWOT Analysis
10.8 Cisco Systems, Inc.
10.8.1 Company Overview
10.8.2 Financial Analysis
10.8.3 Regional Analysis
10.8.4 Research & Development Expense
10.8.5 Recent strategies and developments:
10.8.5.1 Partnerships, Collaborations, and Agreements:
10.8.6 SWOT Analysis
10.9 Dassault Systemes SE
10.9.1 Company Overview
10.9.2 Financial Analysis
10.9.3 Regional Analysis
10.9.4 Research & Development Expense
10.9.5 Recent strategies and developments:
10.9.5.1 Partnerships, Collaborations, and Agreements:
10.9.6 SWOT Analysis
10.10. UnitedHealth Group, Inc. (Optum, Inc.)
10.10.1 Company Overview
10.10.2 Financial Analysis
10.10.3 Segmental Analysis

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us